Biotech Values

[dewophile]

PS: the fact IR mentioned in yesterday's interview that they hope to find a partner later this year or next for IL-21 actually increases the prospects in my view - after all the studies are all open label so the company is seeing the data in real time and most of the studies are wrapping up